GRIN2A and schizophrenia: Our findings illuminate the roles of GluN2A-containing NMDA receptors in the regulation of the E/I balance and demonstrate that targeted antagonism of GluN2A can alter local microcircuits in the dmPFC, potentially leading to antidepressant-like and schizophrenia-like behavioral phenotypes.